Log In
BCIQ
Print this Print this
 

Ebrantil (Urapidil)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionAdrenergic receptor alpha 1 (ADRA1) antagonist
Molecular Target Adrenergic receptor alpha 1 (ADRA1)
Mechanism of ActionAdrenergic receptor alpha 1 (ADRA1) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat high blood pressure
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/10/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today